Drs. Catriona Jamieson and Benjamin Yu are among four UCSD researchers to receive New Faculty II grants from the California Institute for Regenerative Medicine (CIRM).

Catriona Jamieson, M.D., Ph.D., is Assistant Professor of Medicine in the Division of Hematology-Oncology and Director of Stem Cell Research at the Moores UCSD Cancer Center.

Dr. Jamieson investigates stem-cell treatments for myeloproliferative diseases (MPD), with the goal of preventing MPD from developing into leukemia. Read the public abstract for Dr. Jamieson’s research project

Benjamin D. Yu, M.D., Ph.D., is Assistant Professor of Medicine in the Division of Dermatology.

The CIRM grant will support Dr. Yu’s work to uncover the mechanisms that regulate the proliferation of pre-existing adult stem cells in the body. Read the public abstract for Dr. Yu’s research project

   


Read the full story
from UC San Diego
Health Sciences Communications


Read the
San Diego
Union-Tribune
story


More Information

Early childhood is the time to start lowering cholesterol to prevent heart disease, according to Dr. Daniel Steinberg and colleagues at UCSD.
Daniel Steinberg, M.D., Ph.D., is Emeritus Professor of Medicine in the Division of Endocrinology & Metabolism. He is renowned for his groundbreaking research in cholesterol and atherosclerosis.  
Read the full story
from UC San Diego
Health Sciences Communications


His colleagues and co-authors, Christopher K. Glass, M.D., Ph.D., and Joseph Witztum, M.D., are both professors of medicine. All three researchers are members of the Division of Endocrinology & Metabolism.
Their analysis and recommendations are published in the August 5 issue of the journal Circulation.
The full citation for the article:
Steinberg, Daniel MD, PhD; Glass, Christopher K. MD, PhD; Witztum, Joseph L. MD. Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia. Circulation 2008 August 5;118(6):172-177. - Read the article (PDF)
More Information

UCSD pulmonary disease specialist Timothy Morris, M.D., has received the California Thoracic Society’s Outstanding Clinician Award for 2008.  
Read the full story
from UCSD Health Sciences Communications


The award recognizes Dr. Morris for the extraordinary quality of care he provides for patients who have respiratory disorders.Dr. Morris is Professor of Medicine and Medical Director of Clinical Services for the Division of Pulmonary & Critical Care Medicine.In addition, he is Medical Director of the Respiratory Care and the Pulmonary Function Laboratories.  
More Information

David H. Broide, M.B., Ch.B., joined an elite group of physicians from around the world when he was inducted into the prestigious Association of American Physicians (AAP) in April, 2008.
A deeply respected clinician and physician scientist, Dr. Broide is Professor of Medicine and Director of the Research Training Program in the Section of Allergy/Immunology in the Division of Rheumatology, Allergy & Immunology at UC San Diego.   Dr. David H. Broide
Dr. David H. Broide
He is one of only 55 physicians elected to the AAP this year.Dr. Broide devotes his patient care and his research to the treatment of asthma and allergic disorders. In his laboratory, he studies airway remodeling, which is the slow and irreversible damage that asthma produces in the bronchial tubes of a subset of asthmatics.“Finding new therapies is our goal,” Dr. Broide says.He seeks to discover precisely what causes the airway damage and how it can be stopped.
The causes are complex, but there is hope for new treatments
Severe asthma affects approximately 5-10% of individuals who have the disease, but it accounts for about half of the healthcare costs of asthma, which total $8 billion a year in the U.S.Patients who have the severe form of asthma live with frequent emergency room visits and hospitalizations, the need for a variety of medications, and the loss of productivity that comes with a serious chronic illness.Approximately 4,000 to 5,000 individuals die from asthma each year in the U.S.
Dr. Broide says the causes of asthma are complex and are not fully understood.“Asthma,” he says, “is an example of a disease that has both a genetic as well as an environmental contribution.“Over 100 genes have been linked to asthma, and probably more haven’t been discovered.”No single gene has been found to be responsible for more than about 5% of the cases of asthma.  


In the genetics
of asthma,
Dr. Broide looks for
new treatment
possibilities.


Because so many gene products are involved in causing asthma, it has not been effective to treat it by targeting individual genes. An alternative strategy is to identify and block the “master genes” that regulate groups of other genes.One such master gene, NF-ΚB, controls many genes that are important to asthma. It’s therefore a potential therapeutic target.If a compound can block NF-ΚB in the bronchial tubes, it could potentially be effective in treating asthma.One of Dr. Broide’s chief collaborators in this effort is Michael Karin, Ph.D., Professor of Pharmacology in the Laboratory of Gene Regulation and Signal Transduction at UC San Diego. Dr. Karin is an authority on NF-ΚB.
In a study with Dr. Karin, Dr. Broide and his laboratory found that inactivating NF-ΚB in the epithelial cells lining the interior of the bronchial tubes of mice results in a significant improvement in airway remodeling and other features of airway remodeling induced by long-term exposure to inhaled allergens.The study was published in the Proceedings of the National Academic of Sciences in 2006. Read the article (free full text)  


Targeting
a master gene
in asthma:
early results
are promising


Recent discoveries uncover new treatment possibilities
“The field of immunology and asthma is full of opportunities for new discoveries,” Dr. Broide says. “It’s an exciting time to be in the field, which is changing very rapidly.“We have a lot of interesting molecular advances in the field that will provide an opportunity to devise new therapies and better treat our patients.”One such molecular advance is the study of Toll like receptor-9 (TLR-9) vaccines in allergy. Activation of TLR-9 receptors inhibits allergic responses in mouse models of allergy and asthma.In an NIH-sponsored Immune Tolerance Network study, Dr. Broide in collaboration with Dr. Peter S. Creticos at Johns Hopkins University demonstrated that a TLR-9 vaccine significantly improved symptoms of sinus allergies in patients with ragweed allergy.

The study was published in the New England Journal of Medicine in 2006. Read the article (free full text)

As this was a small pilot study, Dr. Broide says, further large-scale studies are needed to determine the effectiveness and safety of this approach.
Inspired to find better treatments for asthma sufferers
Dr. Broide is originally from South Africa, where he received his M.D. from the University of Cape Town and completed his internship at Groote Schuur Hospital in Cape Town.During his internal medicine residency training at the Peter Bent Brigham Hospital in Boston, he became inspired to work in the field of asthma and immunology.From asthma and allergy specialists he learned of the hope that could be offered to the majority of asthma sufferers, and of the need to develop better treatments for those who have severe disease.
Dr. Broide came to UC San Diego for his Allergy and Immunology fellowship training in 1984. He joined the faculty in 1987.He has received many academic and scientific honors. He has been named one of the Best Doctors in America each year since 1998.From 2000 to 2005, he was on the Board of Directors of the American Board of Allergy and Immunology.  

Dr. Broide directs an NIH training grant that supports physician-scientists in translational research in allergy and immunology


He is currently Associate Editor of the Journal of Allergy and Clinical Immunology.Dr. Broide is principal investigator of several NIH grants, including a MERIT award that provides research support for up to 10 years to NIH-funded researchers whose research is highly meritorious.He is also principal investigator of an NIH-sponsored Asthma and Allergic Disease Center at UC San Diego. The center focuses on improving our understanding and therapy of airway remodeling in asthma.Dr. Broide also directs an NIH T32 training grant that supports physician-scientists in translational research in allergy and immunology. Translational research is a high priority in the UC San Diego Department of Medicine.

Physician-scientists supported by this NIH training grant include Allergy/Immunology fellows Dr. Taylor Doherty and Dr. Chavi Gandhi, who are recent UC San Diego Internal Medicine chief residents.

“Physician-scientists are able to bring an important clinical perspective into their basic research studies,” Dr. Broide says.

The aim is to design laboratory studies in a way that leads to better diagnosis and treatment as quickly and safely as possible.

“In particular, we’re trying to help the 10% of severe asthmatics that don’t do that well on current asthma therapies,” Dr. Broide says. “That’s the challenge.”

More Information

Dr. Beatrice Golomb and colleagues are launching a clinical trial of the antioxidant Coenzyme Q10 (CoQ10) for treating symptoms of Gulf War illness.
The study is part of Dr. Golomb’s ongoing efforts to understand and treat Gulf War veterans’ illnesses. The trial is funded by the United States Department of Defense.Beatrice Golomb, M.D., Ph.D., is Associate Professor of Medicine in the Division of General Internal Medicine. On staff at the Veterans Administration San Diego Healthcare System, she is a primary care physician for veterans.

She is a respected leader in Gulf War illness research and policy.

She also directs the UC San Diego Statin Effects Study.

 
Read the full story
from UC San Diego
Health Sciences Communications


More Information

Hospitalists Weijen Chang, M.D., and Joel Trambley, M.D., Ph.D., have received the 2008 Medicine 401 “Excellence in Teaching” award for their outstanding contributions to the core clerkship course.   NAME
Weijen Chang, M.D.
They were honored at the annual Medicine 401 Faculty and Resident Appreciation Reception on June 4, 2008.Dr. Chang, Assistant Clinical Professor of Medicine in the Division of Hospital Medicine, specializes in pediatrics and hospital medicine. He provides hospitalist inpatient services at Thornton Hospital and UC San Diego Medical Center Hillcrest and is a pediatric hospitalist at Rady Children’s Hospital.

Dr. Chang completed his residency training in Internal Medicine/Pediatrics at Duke University in Durham, NC. Formerly Director of the Division of Hospital Medicine at Dartmouth-Hitchcock Medical Center in Manchester, NH, he joined the UC San Diego Hospital Medicine staff in October, 2007.

Dr. Trambley is Assistant Clinical Professor of Medicine in the Division of Hospital Medicine. He joined UC San Diego from the Physician Foundation at California Pacific Medical Center, where he was a hospitalist with the Liver Disease Management and Transplantation Program.

 
More Information

Dr. Martina Buck, faculty researcher in the Division of Gastroenterology, has developed the first tissue culture system for the Hepatitis C virus.
The system offers a model in which investigators can more easily test potential treatments for Hepatitis C.Martina Buck, Ph.D., is Assistant Professor of Medicine in the Division of Gastroenterology and a researcher in the Tumor Growth, Invasion and Metastasis Program at the Moores UCSD Cancer Center.

Her report is published in PLoS ONE:

 
Read the full story
from UC San Diego
Health Sciences Communications


Buck M (2008) Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures. PLoS ONE 3(7): e2660. doi:10.1371/journal.pone.0002660
Read the report (free full text)
More Information


Four UC San Diego Department of Medicine subspecialties are among the top in the nation in the 2008 “Best Hospitals” list from U.S. News & World Report:
America's Best Hospitals  

The report was released July 10.
 


Read the full story
from UC San Diego
Health Sciences
Communications


More Information

A research team led by Dr. Joachim H. Ix has found that individuals who have higher levels of a particular liver protein are at a greater risk for developing Type 2 diabetes.
Dr. Joachim H. Ix, M.D., M.A.S., is Assistant Professor of Medicine in the Division of Nephrology.The study, which included investigators from UC San Francisco and other U.S. Centers, is published in the Journal of the American Medical Association.

The findings may lead to new methods for predicting who will develop Type 2 diabetes and treating the disease.

 
Read the full story
from UC San Diego
Health Sciences Communications
Read the San Diego
Union-Tribune coverage


Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG for the Health ABC Study: Fetuin-A and Incident Diabetes Mellitus in Older Persons. JAMA 2008;300(2):182-188.
Read the report in JAMA
More Information

Department of Medicine professors Dennis A. Carson, M.D., and Webster Cavenee, Ph.D., are among several UC San Diego researchers to win new grants from the California Institute for Regenerative Medicine (CIRM).
The grants come from a CIRM program that provides seed funding for promising stem cell studies.The goal is to hasten the development of new treatments for specific diseases.

Dr. Carson, Director of the Moores UCSD Cancer Center, is Professor of Medicine in the Division of Rheumatology, Allergy, and Immunology.

His project will investigate new models for developing treatments that destroy leukemia stem cells. Read the abstract of Dr. Carson’s project.

Dr. Cavenee, Director of the San Diego branch of the Ludwig Institute for Cancer Research, is Professor of Medicine in the Division of Hematology/Oncology.

Dr. Dennis Carson
Dennis A. Carson, M.D.

Dr. Webster Cavenee
Webster Cavenee, Ph.D.

His study will explore the use of neural stem cells to treat brain tumors. Read the abstract of Dr. Cavenee’s project.CIRM, a continuing partner and major contributor to UC San Diego’s stem cell research programs, announced the awards on June 27.
More Information

In a UC San Diego clinic, a patient is describing his symptoms to a medical student. The student asks questions and listens closely to discover the patient’s chief concern.

It’s a normal part of her fourth-year clinical training – except that another medical student is observing and filming the entire encounter.

When the visit is over, she’ll watch the video and listen to the other student’s comments about her communication skills. Then he’ll hand her the camera. He’ll interview the next patient, and she’ll do the filming and the feedback.They’re taking part in the Paired Observation and Video Editing (POVE) project at UC San Diego.

The project is testing a new method for teaching and learning the skills that make a doctor a good communicator.

 

Kristin Bell, MD
UC San Diego POVE project leader Kristin Bell, M.D., Assistant Professor of Medicine.

UC San Diego is one of 10 centers participating in the 3-year POVE project. The project is conducted as a fourth-year elective, MED 472, in the School of Medicine curriculum.
Peer learning is powerful

Year 1 of POVE has just ended, with medical students Christine Lee and Ninad Athale completing the elective last December.

“The feedback they gave one another was amazing,” says Dr. Kristin Bell, Associate Professor of Medicine in the Division of General Internal Medicine. “They taught each other.”

As Principal Investigator of the POVE Project site at UC San Diego, Dr. Bell is the course director.“It was really great to watch their progress, and it was a unique learning experience for me as well,” she says.

“I think it’s very powerful to learn from your peers.”

 

The goal is to teach the skills that make a doctor a good communicator.


Students produce a “before and after” videoThe POVE course is a four-week, full-time intensive in doctor-patient communication. The medical students work in pairs, taking turns at filming and critiquing.

All of the filming is done with the patients’ consent.

The students meet with Dr. Bell and Ellen Lavin, Ph.D., a clinical psychologist, in weekly video review sessions to talk about the interactions they find challenging.

The film footage records their progress.

At the end of the course, the students extract the best “before” and “after” clips and produce a video essay that highlights the interactions they found difficult and the ways they addressed them.  

“You can learn a lot from your medical student peers.”


On December 7 of last year, POVE students Lee and Athale presented their video essays at an interactive seminar for fellow students, residents, and faculty.“They did an amazing job,” Dr. Bell says.

The students’ videos will become resources for medical centers across the nation after the study is concluded.

UC San Diego part of “a nationwide learning community”

Seeing the videos and having the immediate peer feedback, which Dr. Bell says was delivered with great sensitivity, helped the medical students pinpoint the interactions they found challenging.

The goal is to train the students to be their own observers. Once they are able to recognize precisely the communication skills they want to refine, they are better equipped to improve their interactions with patients.

Studies show that when a doctor communicates in an effective and caring way, patient satisfaction goes up and the average length of a clinic visit actually goes down. Both doctor and patient find the experience more positive.  

A University of Washington therapist and educator is the POVE project leader.


A total of 4 students from UC San Diego will be part of the POVE study, but more may enroll in the course if they are interested. Dr. Bell is now recruiting two students for the Fall 2008 session.

The POVE project is headed by the Department of Family Medicine at the University of Washington. Larry Mauksch, M.Ed., a University of Washington family therapist and the overseeing investigator, calls it “a nationwide learning community.”

Funding for the POVE study comes from the Arthur Vining Davis Foundations, whose healthcare grants are devoted to advancing caring attitudes in medical professionals.

The participating centers include community-based clinics as well as academic Family Medicine and Internal Medicine departments.

Dr. Bell credits many individuals who have worked to make the POVE project possible here. Many School of Medicine colleagues have been greatly supportive, she says, including Jess Mandel, MD, Associate Dean of Undergraduate Medical Education (UGME), and the UGME Electives Committee.

Looking to the future Dr. Bell considers how the POVE experience will influence the medical school curriculum in the future.
“Can you do more peer learning?” she says. “I think you can. You can learn a lot from your medical student peers. It’s instruction from someone you can relate to.”  

“It’s powerful to see a video. As a teaching tool, it’s just limitless.”


She hopes that the POVE course concept will eventually be incorporated into the new curriculum in a different form.

“As it is, the course is very time consuming,” she says. “When we design a course for the new curriculum, we need to set aside enough time to make it effective for student learning, and at the same time keep it sustainable with the faculty resources available.”

“It’s powerful to see a video. As a teaching tool, it’s just limitless.”

More about Kristin Bell, M.D. Dr. Kristin Bell has been a primary care physician and educator at UC San Diego since 2001. She is based at the VA San Diego Healthcare System’s Vista Clinic, where she is Physician Site Leader.

Challenged to help veterans manage chronic pain conditions, she has trained as an acupuncturist and founded an acupuncture clinic at the VA.

A grateful patient nominated her for the American Medical Association’s Young Physician Award, which was granted to her last fall.An emphasis upon doctor-patient communication was built in to her own residency training, she says. She’s a graduate of the Primary Care track in the Medicine program at UC San Francisco.  

“For me, the POVE project
is a great learning experience.”


She’s relatively new to video production, but she has a longtime passion for medical education.

She chose to develop a new behavioral medicine curriculum in her project for her National Center of Leadership in Academic Medicine (NCLAM) course.

It grew into an addition to the third-year Medicine Core Clerkship.

That course also uses video, among other teaching methods, to teach medical students behavioral change counseling and motivational interviewing. The goal is to help patients make healthy lifestyle changes.

It has been a required part of the curriculum here for the past three years.

Dr. Bell acknowledges and thanks her mentors Shawn Harrity, M.D., and Peggy Wallace, Ph.D., for encouraging her and helping her attain success in this area of education.

Dr. Harrity is Clinical Professor of Medicine in the Division of General Internal Medicine. Dr. Wallace is Associate Adjunct Professor of Medicine and Director of the Professional Development Center in the Office of Undergraduate Medical Education.

“For me,” Dr. Bell says, “the POVE project is a great learning experience. I learn from the other POVE faculty, and especially from our students.”

More Information

The anti-rejection drug sirolimus may protect kidney transplant patients from graft rejection over the long term even when the patients have not taken their anti-rejection medications regularly, a Division of Nephrology research team has found.
The team is headed by Robert Steiner, M.D., Professor of Medicine and Director of Transplant Nephrology, and includes Nitin Khosla, M.D., and Rodolfo Batarse, M.D., Assistant Professor of Medicine.First author Cheri Ye, M.D., presented the results at the 2008 American Transplant Congress in Toronto on May 31:

Ye X, Khosla N, Batarse R, Perkins D, Steiner R: Sirolimus (SRL) Blunts Mitogen Response at Trough (C0) Levels More Than Cyclosporin (CSA) or Tacrolimus (TAC) — A Safeguard for Our Many Long Term Noncompliant Kidney Transplant Patients (KTP’s)?

 
Read the full story
from UC San Diego
Health Sciences Communications


More Information


Nora Laiken, Ph.D., Assistant Dean for Educational Support Services in the School of Medicine and Lecturer in the Department of Medicine and Department of Pharmacology, has been honored with two teaching awards.

Dr. Laiken is the recipient of the Kaiser Excellence in Teaching Award from the first-year students in the School of Medicine and the Excellence in Teaching Award from the second-year students in the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego.

    Dr. Nora Laiken
Nora Laiken, Ph.D.

More Information

This year, Dr. John M. Carethers, Professor of Medicine and Chief of the Division of Gastroenterology, was honored with election to the American Society of Clinical Investigation (ASCI).
ASCI membership is granted to a select number of physician-scientists who have made extraordinary contributions in patient care and research before the age of 45.“John epitomizes the ideals of the ASCI - academic scholarship, teaching and clinical medicine,” says Ken Kaushansky, M.D., Helen M. Ranney Professor and Chair of the Department of Medicine. John M. Carethers, MD

Dr. John M. Carethers,
recently elected to the American Society
for Clinical Investigation, in discussion
with a medical student

“He is one of the true triple threats at UCSD, and all should aspire to achieve John’s high standards and accomplishments.”Dr. Carethers is a groundbreaking cancer researcher and a highly respected educator who has won teaching awards from housestaff, fellows, and the Vice Chancellor. He is the youngest division chief in the Department of Medicine.

Since he became chief in 2004, Dr. Carethers has expanded the faculty and secured several major grants, including the division’s first NIH Center grant for a Digestive Diseases Research Development Center.

In a recent interview, he looked back to his earliest steps on the path to this fruitful career, and to the upbringing that set him in this direction.

“My parents believed in education”John M. Carethers was raised in Detroit, third youngest of 12 children.

“My parents believed in education, and they sacrificed a lot to get us educated,” he says. “They took care of us down to their last penny.”

His father, the only African-American student in his college, graduated in 1948 with a degree in mechanical engineering. At the time, companies in Detroit did not hire African-American engineers. He took a job with the Detroit Water and Sewage Department and worked his way up through the ranks.

On a modest income, John’s parents devoted themselves to providing the structure and the opportunities that best suited each of the children, one of whom was disabled.

“We were all different,” he says. “Different personalities, different strengths.”

All of John’s siblings attended parochial school and adhered to a schedule during their hours at home. Television was reserved for weekends. There were dedicated time periods for homework and for play.


As a child, he knew he wanted to be a doctor.


It started with an encyclopediaAsked when he first became interested in medicine, Dr. Carethers says promptly, “Age 7.”

This was when his parents purchased the Encyclopaedia Britannica. The new books came with a requirement for summer projects: each child must make a weekly presentation on a topic of his or her choice at the Sunday afternoon meal.

Finding himself with the “A” volume, John discovered the section that depicted the human body. He remembers the wonder he experienced as he studied the colored overlays that superimposed muscles over organs over bones.

“Anatomy,” he says, smiling broadly. “Physiology. That was it. I knew I wanted to be a doctor.”

On summer Sundays, at the family table, the children gave their presentations. One of his brothers discussed flags; a sister talked about other cultures. John Carethers, age 7, presented the organ systems of the body.

He went to parochial school until high school, when he transferred to a magnet public high school in Detroit. There, he took college preparatory courses in physics, biology, and organic and inorganic chemistry.


In his college job as a unit clerk
at Detroit Children’s Hospital, he had
his first chance to see medicine from the inside.


He covered several paper routes and he tirelessly cultivated a neighborhood clientele for his lawn mowing and snow shoveling services. When he started college, he had saved three thousand dollars.For the first two years of college, per the family rule, he took public transportation and worked his way through his college courses. Then he purchased a car – for cash.

Although he was certain he wanted to become a doctor, he couldn’t imagine himself as a physician in practice. He had never seen what that life, and the path to it, was like.


First glimpse of medical practice

Then he took a job as a unit clerk at Children’s Hospital in Detroit during college.

“For three and a half years,” he says, “I published the OR schedule, made sure the operating doctors had privileges, and recorded the post-anesthesia charts in the computer. I met pediatric surgeons and I got to watch surgeries.”

It was his first inside look at medical practice, and it equipped him to envision his own future.


Although he considered becoming a pediatric surgeon,
“the real diagnosticians are the internists.
That was what interested me.”


Initially, he thought he would become a pediatric surgeon himself. When it came time for his third-year surgery rotation in medical school, however, one of his younger brothers came home with chicken pox and infected the others.That and a postviral syndrome kept Dr. Carethers from immersing in his surgery rotation as he might have done. He did well in it, but by the time the rotation ended, his interest had expanded to other areas of medical practice.

“I thought about it,” he said, “and I felt the real diagnosticians are the internists. That was what interested me.”

During his residency in internal medicine at Massachusetts General Hospital, he determined that he would specialize in gastroenterology. He completed his fellowship training in gastroenterology at the University of Michigan Hospitals and joined the UC San Diego faculty in 1995.

Contributions in cancer research and policy

In the last 10 years, Dr. Carethers and his collaborators have made major discoveries in colon cancer. One of their most significant findings is that patients whose tumors have lost the capacity for DNA mismatch repair are resistant to chemotherapy with 5-fluorouracil, a common anticancer drug. Three other independent research groups have confirmed these findings.

Dr. Carethers and his coworkers demonstrated that this defect is present in 20% of people who have sporadic colon cancer, and in all families who have the hereditary colon cancer that is known as Lynch syndrome.


As a member of an NIDDK commission, he helps to set
national funding priorities for gastroenterology research.


Dr. Carethers is one of 16 appointed members of the National Commission on Digestive Diseases, which was proposed by the American Gastroenterological Association (AGA) and formed by the Director of the National Institutes of Health (NIH) in 2005. The mission of the NCDD is to assess the state of GI research and map out a 10-year plan to accomplish the most promising and pressing research goals.

The Commission advises the NIH Director and Congress, and thus exerts a direct influence on the allocation of federal research funding for GI research projects.

“No one has examined this for 20-30 years,” Dr. Carethers says. The Commission’s next report is due out this summer.

He also holds a two-year position as Vice Chair of the Gastrointestinal Oncology Section of the AGA. In this capacity, he reviews abstracts submitted for the annual AGA meeting. UC San Diego will serve as a host institution as this year’s AGA meeting, known as Digestive Disease Week 2008, convenes in San Diego.

Inspiring and supporting students and trainees

Today, creating ways to inspire young, motivated students is a priority for Dr. Carethers. This has inspired him to work in support of the Preuss School, UC San Diego’s charter middle and high school.

“There are students in the Preuss School who might never have gone to college if they had gone to local schools. But they come to Preuss and see that things could be different. They’re exposed to things they never knew existed.

“We have Preuss students go on to UCSD, Harvard, and other universities,” he says. “I think that’s fantastic.”


“Some people, if they’re given an opportunity,
will take the ball and run with it.”


Supporting his Gastroenterology students and faculty members in their development is important to him as well. He is proud of the training grant that provides protected time for Gastroenterology trainees to do research; he is delighted that the grant has just won a 5-year renewal.

“That’s how I came along,” he said. “I wouldn’t be where I am if I hadn’t had that time to develop.”

He has also established a permanent GI Division Research and Junior Faculty Development Committee to school senior fellows and junior faculty in the UC San Diego promotion process.

“It’s designed to help them navigate the academic process more smoothly,” he says. “No one tells you this stuff.”

In 2006, he received the UC San Diego School of Medicine Vice Chancellor’s Award for Mentoring Excellence.

He speaks warmly of his own mentor, C. Richard Boland, who was Chief of Gastroenterology from 1995 to 2003. Dr. Boland is now at Baylor in Dallas.

“He’s my mentor and friend for life,” he says.

“Through education, we had opportunities”

Dr. Carethers recalls the efforts of his parents, whose values carry on in him and in his siblings.

“Through education, we had opportunities,” he says. “If someone never has the opportunity, they have no idea what they’re missing. Some people never achieve because they never got the opportunity.

“But some people, if they’re given an opportunity, will take the ball and run with it.”

Today, 11 of the 12 Carethers children are college graduates. Among them, they have 21 college degrees.

More Information


The Medical Staff Executive Committee has honored Dr. Brian Kolski with one of its two Housestaff of the Year awards for 2008.

Dr. Kolski is a chief resident in Internal Medicine for the year 2007-2008.

Upon his graduation in June, he will enter a fellowship in cardiology here at the UC San Diego School of Medicine.

   


Read the full story
from UC San Diego
Health Sciences Communications